Alliance Pharma plc (LON:APH – Get Rating)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 94 ($1.15) and last traded at GBX 95.10 ($1.17), with a volume of 1080876 shares trading hands. The stock had previously closed at GBX 96 ($1.18).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank restated a “buy” rating and set a GBX 145 ($1.78) target price on shares of Alliance Pharma in a research report on Thursday, July 14th.
Alliance Pharma Trading Up 0.6 %
The company has a current ratio of 2.00, a quick ratio of 1.40 and a debt-to-equity ratio of 42.11. The company has a market capitalization of £515.99 million and a P/E ratio of 9,560.00. The business has a 50 day moving average price of GBX 110.03 and a 200 day moving average price of GBX 110.29.
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products.
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- There Are Different Types of Stock To Invest In
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn’t Ignore
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.